• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌和肠道微生物群对 Th17 细胞的影响。

The effect of probiotics and gut microbiota on Th17 cells.

机构信息

Graduate School of Biosphere Science, Hiroshima University , Higashihiroshima , Japan.

出版信息

Int Rev Immunol. 2013 Oct-Dec;32(5-6):511-25. doi: 10.3109/08830185.2013.839665. Epub 2013 Oct 4.

DOI:10.3109/08830185.2013.839665
PMID:24094077
Abstract

Probiotics and gut microbiota have a significant impact on gut homeostasis in the host. Recent clinical studies demonstrated the ameliorative features of several kinds of probiotics in intestinal disorders, such as inflammatory bowel diseases (IBDs). Interleukin (IL)-17 is a potent inflammatory cytokine, and T-helper (Th)17 cells and other IL-17-producing cells are involved in the pathogenesis of IBD. Multiple mechanisms of action have been suggested to explain the protective anti-inflammatory effects of probiotics in intestinal inflammation, including the immunoregulation and suppression of Th17 activity and IL-17 production in part by signaling through pattern-recognition receptors such as Toll-like receptor family. However, steady-state Th17 cells have an important role in host defense against fungi and bacteria. Interestingly, recent studies revealed that specific commensal bacterial species such as segmented filamentous bacteria (SFB) induce the accumulation of Th17 cells in the small intestine in many species, including mice. It is important to determine the mechanisms by which intestinal Th17 cells are induced by SFB and whether these or other bacteria with similar properties are present in the human intestine. This brief review focuses on the interaction between probiotics/microbiota and Th17 cells during inflammation (war) and during steady-state homeostatic regulation (peace).

摘要

益生菌和肠道微生物群对宿主的肠道内稳态有重大影响。最近的临床研究表明,多种益生菌可改善肠道疾病,如炎症性肠病(IBD)。白细胞介素(IL)-17 是一种有效的炎症细胞因子,辅助性 T 细胞 17(Th17)细胞和其他产生 IL-17 的细胞参与 IBD 的发病机制。有多种作用机制被提出来解释益生菌在肠道炎症中的保护抗炎作用,包括通过模式识别受体(如 Toll 样受体家族)的信号传导来调节免疫和抑制 Th17 活性和 IL-17 产生。然而,稳态 Th17 细胞在宿主防御真菌和细菌方面发挥着重要作用。有趣的是,最近的研究表明,特定的共生细菌种类,如分段丝状菌(SFB),在包括小鼠在内的许多物种中诱导小肠中 Th17 细胞的积累。确定 SFB 诱导肠道 Th17 细胞的机制,以及是否存在具有类似特性的其他细菌,这一点很重要。这篇简短的综述重点介绍了益生菌/微生物群与 Th17 细胞在炎症(战争)和稳态内稳态调节(和平)期间的相互作用。

相似文献

1
The effect of probiotics and gut microbiota on Th17 cells.益生菌和肠道微生物群对 Th17 细胞的影响。
Int Rev Immunol. 2013 Oct-Dec;32(5-6):511-25. doi: 10.3109/08830185.2013.839665. Epub 2013 Oct 4.
2
Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad.Th17 细胞因子在炎症性肠病中的作用:辨别好坏。
Int Rev Immunol. 2013 Oct-Dec;32(5-6):526-33. doi: 10.3109/08830185.2013.823421. Epub 2013 Sep 16.
3
Functional plasticity of Th17 cells: implications in gastrointestinal tract function.Th17 细胞的功能可塑性:对胃肠道功能的影响。
Int Rev Immunol. 2013 Oct-Dec;32(5-6):493-510. doi: 10.3109/08830185.2013.834899. Epub 2013 Sep 16.
4
The Th17 cell population and the immune homeostasis of the gastrointestinal tract.Th17 细胞群与胃肠道的免疫稳态。
Int Rev Immunol. 2013 Oct-Dec;32(5-6):471-4. doi: 10.3109/08830185.2013.843983.
5
Gut microbiota and probiotics in modulation of epithelium and gut-associated lymphoid tissue function.肠道微生物群和益生菌在调节上皮和肠道相关淋巴组织功能中的作用。
Int Rev Immunol. 2009;28(6):397-413. doi: 10.3109/08830180903215613.
6
Effects of the modulation of microbiota on the gastrointestinal immune system and bowel function.调节肠道菌群对胃肠道免疫系统和肠道功能的影响。
J Agric Food Chem. 2013 Oct 23;61(42):9977-83. doi: 10.1021/jf402441f. Epub 2013 Oct 15.
7
Inflammatory bowel disease, gut bacteria and probiotic therapy.炎症性肠病、肠道细菌和益生菌治疗。
Int J Med Microbiol. 2010 Jan;300(1):25-33. doi: 10.1016/j.ijmm.2009.08.004. Epub 2009 Oct 2.
8
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.辅助性T细胞17作为炎症性肠病潜在的益生菌治疗靶点
Int J Mol Sci. 2015 Sep 1;16(9):20841-58. doi: 10.3390/ijms160920841.
9
Microbial deprivation, inflammation and cancer.微生物剥夺、炎症与癌症。
Cancer Metastasis Rev. 2011 Jun;30(2):211-23. doi: 10.1007/s10555-011-9284-1.
10
Lactobacillus acidophilus Improves Intestinal Inflammation in an Acute Colitis Mouse Model by Regulation of Th17 and Treg Cell Balance and Fibrosis Development.嗜酸乳杆菌通过调节Th17和Treg细胞平衡及纤维化发展改善急性结肠炎小鼠模型的肠道炎症。
J Med Food. 2018 Mar;21(3):215-224. doi: 10.1089/jmf.2017.3990. Epub 2018 Jan 16.

引用本文的文献

1
Gut microbiome dysregulation in noninfectious uveitis.非感染性葡萄膜炎中的肠道微生物群失调
Front Immunol. 2025 Jul 29;16:1614304. doi: 10.3389/fimmu.2025.1614304. eCollection 2025.
2
Gut Feelings: How Microbes, Diet, and Host Immunity Shape Disease.直觉:微生物、饮食与宿主免疫如何塑造疾病
Biomedicines. 2025 May 31;13(6):1357. doi: 10.3390/biomedicines13061357.
3
Perspectives on Microbiome Therapeutics in Infectious Diseases: A Comprehensive Approach Beyond Immunology and Microbiology.传染病中微生物组疗法的展望:超越免疫学和微生物学的综合方法。
Cells. 2024 Dec 4;13(23):2003. doi: 10.3390/cells13232003.
4
Gut-Brain Axis a Key Player to Control Gut Dysbiosis in Neurological Diseases.肠脑轴:控制神经疾病中肠道菌群失调的关键因素
Mol Neurobiol. 2024 Dec;61(12):9873-9891. doi: 10.1007/s12035-023-03691-3. Epub 2023 Oct 18.
5
Mutual interaction of microbiota and host immunity during health and diseases.健康与疾病过程中微生物群与宿主免疫的相互作用。
Biophys Rep. 2021 Aug 31;7(4):326-340. doi: 10.52601/bpr.2021.200045.
6
Gut microbiome profiles and associated metabolic pathways in patients of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies.患有抗干扰素-γ自身抗体的成人发病免疫缺陷患者的肠道微生物群特征及相关代谢途径
Sci Rep. 2022 Jun 1;12(1):9126. doi: 10.1038/s41598-022-13289-9.
7
Effective Regulation of Gut Microbiota With Probiotics and Prebiotics May Prevent or Alleviate COVID-19 Through the Gut-Lung Axis.使用益生菌和益生元有效调节肠道微生物群可能通过肠-肺轴预防或减轻 COVID-19。
Front Pharmacol. 2022 Apr 25;13:895193. doi: 10.3389/fphar.2022.895193. eCollection 2022.
8
Nutraceuticals in the Modulation of the Intestinal Microbiota: Current Status and Future Directions.营养保健品对肠道微生物群的调节作用:现状与未来方向
Front Pharmacol. 2022 Mar 18;13:841782. doi: 10.3389/fphar.2022.841782. eCollection 2022.
9
A novel probiotic strain exerts therapeutic effects on mouse model of multiple sclerosis by altering the expression of inflammasome and IDO genes and modulation of T helper cytokine profile.一种新型益生菌菌株通过改变炎症小体和 IDO 基因的表达以及调节辅助性 T 细胞细胞因子谱,对多发性硬化症的小鼠模型发挥治疗作用。
Metab Brain Dis. 2022 Jan;37(1):197-207. doi: 10.1007/s11011-021-00857-7. Epub 2021 Nov 10.
10
Role of Interleukin-17 in Acute Pancreatitis.白细胞介素-17 在急性胰腺炎中的作用。
Front Immunol. 2021 Sep 14;12:674803. doi: 10.3389/fimmu.2021.674803. eCollection 2021.